NCT05357456

Brief Summary

This is a single center, prospective, observational study to explore and evaluate the differences on cognitive function and brain function by functional-MRI in autonomous cortisol secretion patients, and the different treatments methods on the cognitive function and brain function in patients with autonomous cortisol secretion

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P25-P50 for all trials

Timeline
5mo left

Started Oct 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress92%
Oct 2021Oct 2026

Study Start

First participant enrolled

October 1, 2021

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

April 27, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 2, 2022

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Expected
Last Updated

May 2, 2022

Status Verified

April 1, 2022

Enrollment Period

3 years

First QC Date

April 27, 2022

Last Update Submit

April 27, 2022

Conditions

Keywords

cognitive functionfunctional MRItreatment

Outcome Measures

Primary Outcomes (8)

  • Participants' personal information

    Self-reported information(education in years)

    1 day

  • Physical assessments

    BMI(body mess index) in kg/m\^2

    1 day

  • Imaging examinations

    Adrenal adenoma size in cm

    1 day

  • Montreal Cognitive Assessment (MoCA)

    The MoCA is a Global cognitive screening test designed to assist Health Professionals in detection of mild cognitive impairment.

    20 minutes

  • Mini-Mental State Examination (MMSE)

    The MMSE is a cognitive screening test designed to assist Health Professionals in detection of mild cognitive impairment.

    20 minutes

  • Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)

    The RBANS is a cognitive screening test designed to assist Health Professionals in evaluation of multiple cognitive subdomains

    1 hour

  • Rest Functional MRI of the brain function.

    Rs-fMRI

    40 minutes

  • Screening for adrenal cortisol hypersecretion

    Patients were given 1 mg dexamethasone orally at 24:00 am, and the cortisol levels were measured at 8:00 am the following morning

    1 day

Secondary Outcomes (6)

  • Changes from basline global cognitive functions

    12 months after the laparoscopic adrenal surgery (for patients with autonomous cortisol secretion who are willing to operate)]

  • Changes from basline multiple cognitive subdomains

    12 months after the laparoscopic adrenal surgery (for patients with autonomous cortisol secretion who are willing to operate)]

  • Change from baseline Functional magnetic resonance imagine

    12 months after the laparoscopic adrenal surgery (for patients with autonomous cortisol secretion who are willing to operate)]

  • Changes from basline global cognitive functions

    12 months after the conservative treatment (for patients with autonomous cortisol secretion who are not willing to operate)]

  • Changes from basline multiple cognitive subdomains

    12 months after the conservative treatment (for patients with autonomous cortisol secretion who are not willing to operate)]

  • +1 more secondary outcomes

Study Arms (2)

autonomous cortisol secretion

Patients admitted to the hospital with adrenal incidentalomas are evaluated for adrenal function, and then ACS patients are diagnosed based on the serum cortisol ≥ 50 nmol/L following the 1 mg dexamethasone suppression test and without any other signs or symptoms of cortisol excess.Patients with ACS will undergo a physical exam, cognitive function test as well as structural and functional brain MRI at baseline and 12 months after their surgery or conservative treatment.

Behavioral: Cognitive function assessment; functional magnetic resonance imagingProcedure: laparoscopic adrenal surgery

non-functioning adrenal adenomas

Patients admitted to the hospital with adrenal incidentalomas are evaluated for adrenal function, and then non-functioning adrenal adenomas patients are diagnosed based on the serum cortisol \< 50 nmol/L following the 1 mg dexamethasone suppression test .Patients with non-functioning adrenal adenomas will undergo a physical exam, cognitive function test as well as structural and functional brain MRI at baseline.

Behavioral: Cognitive function assessment; functional magnetic resonance imaging

Interventions

cognitive function measurement

Also known as: fMRI
autonomous cortisol secretionnon-functioning adrenal adenomas

Only a subgroup of the autonomous cortisol secretion patients will have the laparoscopic adrenal surgery

autonomous cortisol secretion

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

autonomous cortisol secretion and non-functioning adrenal adenomas patients

You may qualify if:

  • age 20-65 years;
  • ≥ 6 years of education;
  • right-handed;
  • complete entire cognitive function tests;
  • adrenal lesions ≥ 1 cm in diameter;
  • patients with non-functioning adrenal adenomas;
  • patients with autonomous cortisol secretion.

You may not qualify if:

  • \< 6 years of education;
  • age \< 20 years or \> 65 years;
  • maximum diameter of AI \<1cm;
  • active malignancies;
  • with a history of thyroid disease;
  • with a history of acute infection in the last month;
  • central nervous system diseases, including brain trauma, intracranial hemorrhage, acute cerebral infarction, etc;
  • contraindications of MRI examination: such as implantation of metal prosthesis in vivo, claustrophobia, etc;
  • adrenal tuberculosis;
  • suspected or diagnosed adrenocortical carcinoma;
  • unable to complete entire cognitive function tests;
  • current use of steroids or any drugs known to alter steroid synthesis or metabolism in the previous 3 months;
  • clinical Cushing syndrome;
  • Cushing disease;
  • primary hyperaldosteronism;
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Endocrinology, Drum Tower Hospital affiliated to Nanjing University Medical School

Nanjing, Jiangsu, 210008, China

RECRUITING

Related Publications (1)

  • Liu MS, Tian ZY, Zhang Z, Yang F, Lou Y, Wang YJ, Zeng YJ, Zhang ZW, Zhu DL, Li P. Impaired Cognitive Function in Patients With Autonomous Cortisol Secretion in Adrenal Incidentalomas. J Clin Endocrinol Metab. 2023 Feb 15;108(3):633-641. doi: 10.1210/clinem/dgac603.

MeSH Terms

Conditions

Adrenal incidentaloma

Study Officials

  • Dalong Zhu, MD,PhD

    The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dalong Zhu, MD,PhD

CONTACT

PIng Li, MD,PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Physician

Study Record Dates

First Submitted

April 27, 2022

First Posted

May 2, 2022

Study Start

October 1, 2021

Primary Completion

October 1, 2024

Study Completion (Estimated)

October 1, 2026

Last Updated

May 2, 2022

Record last verified: 2022-04

Locations